Antifibrotic in interstitial lung diseases: When, where, and how long?

被引：3
|
作者：
Rai, Deependra K. [1 ]
Tripathi, Suryakant [2 ]
机构：
[1] AIIMS, Dept Pulm Med, Patna, Bihar, India
[2] KJMU, Dept Pulm Med, Lucknow, Uttar Pradesh, India
来源：
LUNG INDIA | 2022年 / 39卷 / 06期
关键词：
IDIOPATHIC PULMONARY-FIBROSIS; FORCED VITAL CAPACITY; DOUBLE-BLIND; PIRFENIDONE; NINTEDANIB; EFFICACY; SAFETY; UPDATE;
D O I：
10.4103/lungindia.lungindia_283_22
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：491 / 494
页数：4
相关论文
共 50 条
  • [21] Impact of antifibrotic therapy on disease progression, all-cause mortality, and risk of acute exacerbation in non-IPF fibrosing interstitial lung diseases: evidence from a meta-analysis of randomized controlled trials and prospective controlled studies
    Li, De-yu
    Liu, Xin
    Huang, Jing-yi
    Hang, Wen-lu
    Yu, Gu-ran
    Xu, Yong
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2024, 18
  • [22] Oxygen for interstitial lung diseases
    Khor, Yet H.
    Smith, David J. F.
    Johannson, Kerri A.
    Renzoni, Elisabetta
    CURRENT OPINION IN PULMONARY MEDICINE, 2020, 26 (05) : 464 - 469
  • [23] Antifibrotic Therapies and Progressive Fibrosing Interstitial Lung Disease (PF-ILD): Building on INBUILD
    Shumar, John N.
    Chandel, Abhimanyu
    King, Christopher S.
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (11)
  • [24] Recent Advances and Future Needs in Interstitial Lung Diseases
    Jones, Mark G.
    Richeldi, Luca
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 37 (03) : 477 - 483
  • [25] Diagnostic and therapeutic upheavals in the world of interstitial lung diseases
    Waelscher, J.
    Kreuter, M.
    PNEUMOLOGE, 2020, 17 (02): : 113 - 119
  • [26] Antifibrotic treatment in progressive non-IPF fibrotic interstitial lung diseases
    Belen Llanos-Gonzalez, Ana
    Bordas Martinez, Jaume
    Bermudo Peloche, Guadalupe
    Suarez-Cuartin, Guillermo
    Vicens Zygmunt, Vanesa
    Planas-Cerezales, Lurdes
    Palma Lopez, Jose Manuel
    Perez Martin, Laura
    Jodar Masanes, Ramon
    Padulles Zamora, Nuria
    Garcia Gil, Sara
    Dorca Sargatal, Jordi
    Medina Gonzalvez, Agustin
    Acosta Fernandez, Orlando
    Molina Molina, Maria
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [27] RESEARCH BURDEN OF INTERSTITIAL LUNG DISEASES IN TURKEY - RBILD
    Aycicek, Olcay
    Cetinkaya, Erdogan
    Ucsular, Fatma Demirci
    Bayram, Nazan
    Senyigit, Abdurrahman
    Aksel, Nimet
    Atilla, Nurhan
    Sarioglu, Nurhan
    Niksarlioglu, Elif Yelda
    Ilgazli, Ahmet
    Kilic, Talat
    Gunbatar, Hulya
    Cilekar, Sule
    Ekici, Aydanur
    Arinc, Sibel
    Bircan, Haci Ahmet
    Duman, Dildar
    Dikis, Ozlem Sengoren
    Yazici, Onur
    Kansu, Abdulla
    Tutar, Nuri
    Ozsari, Emine
    Berk, Serdar
    Varol, Yelda
    Erbaycu, Ahmet Emin
    Sertogullarindan, B. Bunyamin
    Cirak, Ali Kadri
    Cortuk, Mustafa
    Karadeniz, Gulistan
    Simsek, Alper
    Sezgi, C. Cengizhan
    Erel, Fuat
    Ciftci, Tuba
    Sunnetcioglu, A. Aysel
    Ekici, Mehmet Savas
    Gunay, Ersin
    Aca, Meltem
    Ozturk, Onder
    Ogun, Hamza
    Acar, Elif
    Dogan, O. T. Omer Tamer
    Alizoroglu, D. Dursun
    Gezer, Esma
    Ozlu, Tevfik
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2022, 39 (01)
  • [28] Bibliometric analysis of the pirfenidone and nintedanib in interstitial lung diseases
    Liu, Jia
    Wang, Faping
    Hong, Yiwen
    Luo, Fengming
    HELIYON, 2024, 10 (08)
  • [29] Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases
    Sebastiano Emanuele Torrisi
    Nicolas Kahn
    Julia Wälscher
    Nilab Sarmand
    Markus Polke
    Kehler Lars
    Monika Eichinger
    Claus Peter Heussel
    Stefano Palmucci
    Francesca Maria Sambataro
    Gianluca Sambataro
    Domenico Sambataro
    Carlo Vancheri
    Michael Kreuter
    BMC Pulmonary Medicine, 19
  • [30] Impact of Lung Biopsy Information on Treatment Strategy of Patients with Interstitial Lung Diseases
    Tomassetti, Sara
    Ravaglia, Claudia
    Puglisi, Silvia
    Ryu, Jay H.
    Colby, Thomas, V
    Cavazza, Alberto
    Wells, Athol U.
    Pavone, Mauro
    Vancheri, Carlo
    Lavorini, Federico
    Matucci-Cerinic, Marco
    Rosi, Elisabetta
    Luzzi, Valentina
    Gori, Leonardo
    Rossi, Giulio
    Donati, Luca
    Dubini, Alessandra
    Piciucchi, Sara
    Poletti, Venerino
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2022, 19 (05) : 737 - 745
12345